MAHA Must Prepare for the Future of Medicine
Some of the top names in longevity and health—including Brigham Buhler and Gary Brecka—arrived in Washington to weigh in on the latest Make America Healthy Again hot-button issue, raising questions about safety, innovation, and access. The review comes amid growing interest in peptide treatments and concerns that patients seeking these therapies may turn to sources outside traditional medical oversight. It is an early glimpse into the broader questions and debates that will guide the future of American healthcare.
- ▪Some of the top names in longevity and health—including Brigham Buhler and Gary Brecka—arrived in Washington to weigh in on the latest Make America Healthy Again hot-button issue, raising questions about safety, innovation, and access.
- ▪The review comes amid growing interest in peptide treatments and concerns that patients seeking these therapies may turn to sources outside traditional medical oversight.
- ▪It is an early glimpse into the broader questions and debates that will guide the future of American healthcare.
The Daily Signal files mainly under politics. We currently carry 252 of its stories.
Opening excerpt (first ~120 words) tap to expand
Home – RFK Jr & MAHA News – MAHA Must Prepare for the Future of Medicine opinion MAHA Must Prepare for the Future of Medicine Jennifer Galardi | Matthew Lallinger • July 24, 2026 Print (Kevin Carter/Getty Images) (function(){var t=document.querySelector(".wp-block-kadence-dynamichtml"),s=document.currentScript.previousElementSibling;if(t&&s){if("prepend"==="before_element")t.parentNode.insertBefore(s,t);else if("prepend"==="after_element")t.parentNode.insertBefore(s,t.nextSibling);else if("prepend"==="prepend"||"prepend"==="inside_first_child")t.insertBefore(s,t.firstChild);else t.appendChild(s);}})(); This week, the Food and Drug Administration reviewed whether certain peptide therapies should be more widely available through compounding pharmacies.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Daily Signal.